Analysts Estimate electroCore, Inc. (ECOR) to Report a Decline in Earnings: What to Look Out for

Core Insights - electroCore, Inc. (ECOR) is anticipated to report a year-over-year decline in earnings despite an increase in revenues for the quarter ended September 2025 [1] - The upcoming earnings report is expected to be released on November 5, with the stock's movement likely influenced by whether the actual results meet or exceed expectations [2] Financial Expectations - The consensus estimate indicates a quarterly loss of $0.36 per share, reflecting a year-over-year change of -16.1% [3] - Revenues are projected to be $7.85 million, representing a 19.9% increase from the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised down by 4.08% over the last 30 days, indicating a reassessment by analysts [4] - The Most Accurate Estimate for electroCore is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -1.41% [12] Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from the consensus estimate, with a strong predictive power for positive readings [9][10] - electroCore's current Zacks Rank is 3, making it challenging to predict an earnings beat [12] Historical Performance - In the last reported quarter, electroCore was expected to post a loss of $0.32 per share but actually reported a loss of -$0.35, resulting in a surprise of -9.38% [13] - Over the past four quarters, the company has only beaten consensus EPS estimates once [14] Industry Comparison - In the Zacks Medical - Drugs industry, Madrigal (MDGL) is expected to report a loss of $1.99 per share, with a significant year-over-year revenue increase of 300.8% to $249.15 million [18][19] - Madrigal's consensus EPS estimate has been revised up by 29.2% in the last 30 days, and it has a positive Earnings ESP of +27.84%, indicating a likely earnings beat [19][20]